265 related articles for article (PubMed ID: 30267321)
61. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
62. Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Farkas H; Balla Z
Expert Opin Investig Drugs; 2024 Mar; 33(3):191-200. PubMed ID: 38366937
[TBL] [Abstract][Full Text] [Related]
63. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
64. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
65. Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1.
Karadža-Lapić L; Korošec P; Šilar M; Košnik M; Cikojević D; Lozić B; Rijavec M
Ann Med; 2016 Nov; 48(7):485-491. PubMed ID: 27187751
[TBL] [Abstract][Full Text] [Related]
66. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
67. Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema.
Schlueter M; Nestler-Parr S
J Comp Eff Res; 2024 May; 13(5):e230165. PubMed ID: 38545965
[No Abstract] [Full Text] [Related]
68. The role of the complement system in hereditary angioedema.
Csuka D; Veszeli N; Varga L; Prohászka Z; Farkas H
Mol Immunol; 2017 Sep; 89():59-68. PubMed ID: 28595743
[TBL] [Abstract][Full Text] [Related]
69. New treatment options for acute edema attacks caused by hereditary angioedema.
Thomas MC; Shah S
Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
[TBL] [Abstract][Full Text] [Related]
70. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
Magerl M; Germenis AE; Maas C; Maurer M
Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
[TBL] [Abstract][Full Text] [Related]
71. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
72. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
73. Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada.
Iaboni A; Kanani A; Lacuesta G; Song C; Kan M; Betschel SD
Allergy Asthma Clin Immunol; 2021 Jul; 17(1):78. PubMed ID: 34301329
[TBL] [Abstract][Full Text] [Related]
74. The Role of Complement in Hereditary Angioedema.
Levi M; Cohn DM
Transfus Med Rev; 2019 Oct; 33(4):243-247. PubMed ID: 31676220
[TBL] [Abstract][Full Text] [Related]
75. Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors.
Marceau F; Bachelard H; Rivard GÉ; Hébert J
BMC Res Notes; 2019 May; 12(1):291. PubMed ID: 31133046
[TBL] [Abstract][Full Text] [Related]
76. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
Wu MA; Zanichelli A; Mansi M; Cicardi M
Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
[TBL] [Abstract][Full Text] [Related]
77. Lanadelumab (Takhzyro) for prevention of hereditary angioedema.
Med Lett Drugs Ther; 2021 Mar; 63(1619):e41-e42. PubMed ID: 33755657
[No Abstract] [Full Text] [Related]
78. A novel murine in vivo model for acute hereditary angioedema attacks.
Bupp S; Whittaker M; Lehtimaki M; Park J; Dement-Brown J; Zhou ZH; Kozlowski S
Sci Rep; 2021 Aug; 11(1):15924. PubMed ID: 34354123
[TBL] [Abstract][Full Text] [Related]
79. Use of ecallantide in pediatric hereditary angioedema.
MacGinnitie AJ; Davis-Lorton M; Stolz LE; Tachdjian R
Pediatrics; 2013 Aug; 132(2):e490-7. PubMed ID: 23878046
[TBL] [Abstract][Full Text] [Related]
80. Current treatment of hereditary angioedema: An update on clinical studies.
Banerji A
Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
